Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
This grant funds the development and validation of innovative technologies aimed at advancing cancer research.
About this program
The Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research grant supports projects that focus on the creation and validation of new technologies that can enhance cancer research. This funding opportunity is designed for researchers and institutions engaged in both basic and clinical cancer research, providing them with the resources needed to develop tools that can lead to significant advancements in understanding and treating cancer. The grant encourages innovative approaches that can be translated into practical applications in the field of oncology. Eligible applicants include academic institutions, nonprofit organizations, and other research entities that are working on cutting-edge technologies in cancer research. The grant aims to foster collaboration between researchers and technology developers to ensure that the resulting innovations are both scientifically sound and clinically relevant. By funding these projects, the grant seeks to bridge the gap between laboratory discoveries and clinical applications, ultimately improving patient outcomes in cancer treatment.
Eligibility
Academic institutions, nonprofit organizations, and research entities focused on cancer research.